Home › Trial NCT07555678
Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase
- Trial IDNCT07555678
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorFudan University
- Enrollment241
- Start date2024-04-01
- ConditionsAnal Squamous Cell Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.